Company Filing History:
Years Active: 2022
Title: David Pearson - Innovator in Pharmaceutical Chemistry
Introduction
David Pearson is a notable inventor based in Penicuik, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on hydroxynorketamine. His research focuses on developing stable and processable salt forms that enhance the solubility of this compound, which has potential therapeutic applications.
Latest Patents
David Pearson holds a patent for "Crystalline forms of hydroxynorketamine." This invention provides novel, stable, processable, and pharmaceutically acceptable salt forms of 2R,6R-hydroxynorketamine or 2S,6S-hydroxynorketamine with high aqueous solubility. This advancement is crucial for improving the delivery and efficacy of the drug in clinical settings.
Career Highlights
David is currently associated with Small Pharma Ltd, where he continues to push the boundaries of pharmaceutical research. His work is characterized by a commitment to innovation and a focus on developing solutions that address unmet medical needs. With 1 patent to his name, he exemplifies the spirit of invention in the pharmaceutical industry.
Collaborations
David collaborates with talented professionals in his field, including Lorraine Sharp and Alan Armstrong. These partnerships enhance the research environment and contribute to the successful development of new pharmaceutical products.
Conclusion
David Pearson's contributions to pharmaceutical chemistry through his innovative patent on hydroxynorketamine highlight his role as a key inventor in the industry. His work not only advances scientific knowledge but also has the potential to improve patient outcomes.